Profound Bio
AcquiredWelcome to Genmab
Redmond, United States · $237.0M raised
- Headquarters
- Redmond, Washington
- Business Model
- B2B
- Website
- profoundbio.com
- Total Funding
- $237.0M
- Last Round
- $112.0M Series BFeb 2024
- Rounds
- 3
- Acquired by
- Genmab A/SApr 2024 · $1.8B
About
Clinical-stage biotech developing antibody-drug conjugates; acquired by Genmab in 2024.
Summary
Profound Bio is a Biotech company based in Redmond, United States. It has raised $237.0M in total across 3 rounds, most recently a $112.0M Series B round in Feb 2024. Investors include Lilly Asia Ventures, Genmab and Ally Bridge Group.
Tech & App Stack
11 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Apr 2024
Sign up to see all 4 rounds
Series A through Acquisition — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/profound-bio"><img src="https://indexed.vc/api/badge/company/profound-bio" alt="Profound Bio on Indexed.vc" width="260" height="76" /></a>